Infinium Global Research Biologics Safety Testing Market | Page 2

Infinium Global Research has added a new report on Global Biologics Safety Testing Market. The report predicts the market size of
Biologics Safety Testing is expected to reach XX billion by 2023.
The report on global Biologics Safety Testing Market provides qualitative and quantitative analysis for the period of 2017 to 2023.
According to report the global Biologics Safety Testing Market is expected to grow at a CAGR between 12.0% and 12.5 % over the
forecast period of 2017 - 2023. The global market size was USD 2.19 billion in 2015.
Market Insights:
The report identified that Global Biologics Safety Testing is driven by factors such as Number of Drug Launches are increased ,
Technological Advancements, Increase in Biotechnology and Pharmaceutical Industries Driven By Government
Support and Regulations. While the restraining factors include High Cost of Biologics Safety Testing. Further, the report identifies the
opportunities in the world market as Emerging Markets Offer Profitable Growth Opportunities, Increasing Pharmaceutical Outsourcing.
Get a Sample Report @
https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/708
Segments Covered
The report on global biologics safety testing market covers the segments based on instruments and services, test type, and
application. The instruments and services of biologics safety testing include instruments, kits & reagents and services. The
test type segment includes bioburden tests, endotoxin tests, adventitious agent detection tests, cell line
authentication and characterization tests, residual host contaminant detection tests, adventitious agent detection
tests and other test. On the basis of application the global biologics safety testing market is segmented as vaccine &
therapeutics development, tissue and tissue-related products testing, blood and blood-related products testing, stem cell research
and cellular and gene therapy .